NAYA - צמיחת רווחי EPS רבעונית NAYA Biosciences Inc.

NAYA Biosciences develops unique antibodies to combat tumors, protecting its innovations with FLEX-NK patents. The quarterly EPS growth history confirms this potential, where the value 79.80 represents the current figure. Management is focused on raising capital to advance therapy development, while optimizing biomaterial supplies in stable regions minimizes the company's operational risks.

This indicator calculates the percentage change in net earnings per share compared to the same period last year, reflecting the dynamics of the business's actual earnings. For NAYA Biosciences (NAYA), which is in a stage of costly development without sales, the current quarterly EPS growth value on the GURU.Markets platform serves as a marker for the rate of capital expenditure and the company's degree of financial stability.